Clarivate Epidemiology’s coverage of ischemic stroke (IS) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the event rate of IS for each country, as well as annualized case counts projected to the national population.
Clarivate Epidemiology’s IS forecast will answer the following questions:
- How will changes in the levels of exposure to known risk or protective factors affect the number of IS events per year?
- Of all people with IS, how many in each of the major mature pharmaceutical markets have been formally diagnosed?
- Of all people diagnosed with IS, how many in each of the major mature pharmaceutical markets are drug-treated?
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of IS over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In total, Clarivate Epidemiology forecasts 15 IS patient populations, as follows:
- Total events.
- Diagnosed events.
- Diagnosed drug-treated events.
- Diagnosed non-drug-treated events.
- Diagnosed events of 1 hour or less.
- Diagnosed events of 1-2 hours.
- Diagnosed events of 2-3 hours.
- Diagnosed events of 3-4.5 hours.
- Diagnosed events of 4.5-6 hours.
- Diagnosed events of 6-12 hours.
- Diagnosed events of 12-24 hours.
- Diagnosed events of more than 24 hours or time unknown.
- Undiagnosed events.
- Total lifetime prevalence.
- Diagnosed 12-month prevalence.
Note: Coverage may vary by country.
Natasha Nahar
Natasha Nahar, M.P.H., Senior Epidemiologist, Epidemiology. Ms. Nahar holds a master’s degree in public health from the Tata Institute of Social Sciences in Mumbai and a bachelor’s degree in dental surgery from BVDU Dental College and Hospital in Sangli.
Narendra Parihar
Narendra Parihar, B.D.S., M.P.H., Senior Manager, Epidemiology. Dr Parihar is a team lead at Clarivate Epidemiology. He specializes in modelling and forecasting epidemiology patient populations across multiple indications. His primary areas of interest are cancer epidemiology, rare disease epidemiology, and targeted therapies in cancer. His qualifications include a master’s degree in public health with specialization in health policy, economics, and finance from Tata Institute of Social Sciences Mumbai, and a bachelor’s degree in dental surgery from the Rajasthan University of Health Sciences.
Sunali D. Goonesekera, S.M.
Sunali D. Goonesekera, S.M., Senior Manager, Epidemiology. Prior to joining Clarivate, Ms. Goonesekera conducted epidemiological research on racial/ethnic disparities in metabolic diseases at the New England Research Institute and lead-authored two manuscripts. She has contributed to multiple publications in peer-reviewed journals in epidemiology and the biological sciences. She holds a master’s degree in epidemiology from the Harvard School of Public Health and a B.A. in biology (Honors) from Dartmouth College.